Making the business case for enhanced depression care: The national institute of mental health-Harvard work outcomes research and cost-effectiveness study

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 4, 2008, Pages 468-475

  Wang, Philip S ^a,b,c   Simon, Gregory E ^d   Kessler, Ronald C ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; HEALTH CARE MANAGEMENT; HEALTH HAZARD; HUMAN; JOB PERFORMANCE; MEDICAL LITERATURE; MENTAL HEALTH; MENTAL HEALTH SERVICE; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; REVIEW; STATISTICAL SIGNIFICANCE; TELEPHONE; WORLD HEALTH ORGANIZATION;

EID: 42049115229     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31816a8931     Document Type: Article

References (92)

1. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264:2524-2528.
2. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry. 1993;150:720-727.
3. Harwood HJ, Napolitano DM, Kristiansen P, Collins JJ. Economic Costs to Society of Alcohol and Drug Abuse and Mental Illness, 1980. Research Triangle Park, NC: Research Triangle Institute; 1984.
4. Jacob M, Frank E, Kupfer DJ, Carpenter LL. Recurrent depression: an assessment of family burden and family attitudes. J Clin Psychiatry. 1987;48:395-400.
5. Klerman GL, Weissman MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry. 1992;49:831-834.
6. Murray CJL, Lopez AD. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge: Harvard University Press; 1996.
7. Rice DP, Kelman S, Miller LS, Dunnmeyer S. The Economic Costs of Alcohol and Drug Abuse and Mental Illness: 1985. Rockville, MD: Alcohol, Drug Abuse, and Mental Health Administration; 1990.
8. Rohde P, Lewinsohn PM, Seeley JR. Are people changed by the experience of having an episode of depression? A further test of the scar hypothesis. J Abnorm Psychol. 1990;99:264-271.
9. Stoudemire A, Frank R, Hedemark N, Kamlet M, Blazer D. The economic burden of depression. Gen Hosp Psychiatry. 1986;8:387-394.
10. Tweed DL. Depression-related impairment: estimating concurrent and lingering effects. Psychol Med. 1993;23:373-386.
11. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914-919.
12. Zeiss AM, Lewinsohn PM. Enduring deficits after remissions of depression: a test of the scar hypothesis. Behav Res Ther. 1988;26:151-158.
13. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465-1475.
14. Eaton WW, Anthony JC, Mandel W, Garrison R. Occupations and the prevalence of major depressive disorder. J Occup Med. 1990;32:1079-1087.
15. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
16. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. J Occup Environ Med. 1999;41:863-877.
17. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff. 2001;20:233-241.
18. Kessler RC, Mickelson KD, Barber CB, Wang PS. The association between chronic medical conditions and work impairment. In: Rossi AS, ed. Caring and Doing for Others: Social Responsibility in the Domains of Family, Work, and Community. Chicago, IL: University of Chicago Press; 2001:403-426.
19. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-3144.
20. Wang PS, Beck A, Berglund P, et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med. 2003;45:1303-1311.
21. Kessler RC, Foster CL, Saunders WB, Stang PE. Social consequences of psychiatric disorders, I: educational attainment. Am J Psychiatry. 1995;152:1026-1032.
22. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209.
23. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
24. Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284-292.
25. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
26. Agency for Health Care Policy and Research. Depression in primary care. Treatment of Major Depression. Vol. 2. Rockville, MD: US Department of Health and Human Services; 1993.
27. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 2nd ed. Washington, DC: American Psychiatric Association; 2000.
28. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932.
29. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995;273:1026-1031.
30. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-220.
31. Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med. 1997;27:861-873.
32. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ. 1998;17:511-535.
33. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11-19.
34. Ormel J, Koeter MW, Van den Brink W, van de Willige G. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry. 1991;48:700-706.
35. Ormel J, Van den Brink W, Koeter MW, et al. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med. 1990;20:909-923.
36. Ormel J, Von Korff M, Van den Brink W, Katon W, Brilman E, Oldehinkel T. Depression, anxiety, and social disability show synchrony of change in primary care patients. Am J Public Health. 1993;83:385-390.
37. Von Korff M, Ormel J, Katon W, Lin EH. Disability and depression among high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry. 1992;49:91-100.
38. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
39. Finkelstein SN, Berndt ER, Greenberg PE, Parsley RA, Russell JM, Keller MB. Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group. Psychopharmacol Bull. 1996;32:33-40.
40. Kocsis JH, Frances AJ, Voss C, Mason BJ, Mann JJ, Sweeney J. Imipramine and social-vocational adjustment in chronic depression. Am J Psychiatry. 1988;145:997-999.
41. Mauskopf JA, Simeon GP, Miles MA, Westlund RE, Davidson JR. Functional status in depressed patients: the relationship to disease severity and disease resolution. J Clin Psychiatry. 1996;57:588-592.
42. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
43. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry. 1992;49:761-768.
44. Simon GE, Katon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med. 1998;28:693-701.
45. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 1978;166:317-326.
46. Agosti V, Stewart JW, Quitkin FM. Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. J Affect Disord. 1991;23:35-41.
47. Kocsis JH, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry. 1997;154:390-395.
48. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441-445.
49. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry. 1999;56:1109-1115.
50. Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med. 2000;9:345-351.
51. Rost K, Nutting PA, Smith J, Werner JJ. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psychiatry. 2000;22:66-77.
52. Rost K, Smith JL, Dickinson M. The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial. Med Care. 2004;42:1202-1210.
53. Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004;292:935-942.
54. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-554.
55. Klinkman MS. Competing demands in psychosocial care. A model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psychiatry. 1997;19:98-111.
56. Williams JW Jr. Competing demands: does care for depression fit in primary care? J Gen Intern Med. 1998;13:137-139.
57. Crofton C, Lubalin JS, Darby C. Consumer Assessment of Health Plans Study (CAHPS). Foreword. Med Care. 1999;37(Suppl 3):MS1-MS9.
58. National Committee for Quality Assurance. HEDIS 3.0: Narrative: What's in it and Why it Matters. Washington, DC: National Committee for Quality Assurance; 1997.
59. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res. 2003;12:22-33.
60. Wang PS, Simon GE, Avorn J, et al. A randomized controlled trial of telephone screening, outreach, and care management for depressed workers: impact on clinical and work productivity outcomes. JAMA. 2007;298:1401-1411.
61. Hewitt Associates. Health Promotion Initiatives/Managed Health Provided by Major US Employers in 1996. Lincolnshire, IL: Benefit Surveys; 1997.
62. Ryder R. Implementation strategies and applications for health risk appraisals. In: Hyner GC, Peterson KW, Travis JW, Dewey JE, Foerster JJ, Framer EM, eds. SPM Handbook of Health Assessment Tools. Pittsburgh, PA: Society for Prospective Medicine and the Institute for Health and Productivity Management; 1999:179-184.
63. Wang PS, Beck AL, McKenas DK, et al. Effects of efforts to increase response rates on a workplace chronic condition screening survey. Med Care. 2002;40:752-760.
64. Kessler RC, Ames M, Hymel PA, et al. Using the world health organization health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J Occup Environ Med. 2004;46:S23-S37.
65. Kessler RC, Barber C, Beck A, et al. The world health organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45:156-174.
66. Schoenbaum M, Kelleher K, Lave JR, Green S, Keyser D, Pincus H. Exploratory evidence on the market for effective depression care in Pittsburgh. Psychiatr Serv. 2004;55:392-395.
67. Ludman EJ, Simon GE, Tutty S, Von Korff M. A randomized trial of telephone psychotherapy and pharmacotherapy for depression: continuation and durability of effects. J Consult Clin Psychol. 2007;75:257-266.
68. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA. 1999;282:1737-1744.
69. Rollnick S, Mason P, Butler C. Health Behavior Change: A Guide for Practitioners. London: Churchill Livingstone; 1999.
70. Simon GE, Ludman EJ, Tutty S. Creating a Balance: A Step-by-Step Approach to Managing Stress and Lifting Your Mood. Victoria, BC: Trafford Press; 2006.
71. Tutty S, Simon G, Ludman E. Telephone counseling as an adjunct to antidepressant treatment in the primary care system. A pilot study. Eff Clin Pract. 2000;3:170-178.
72. Lewinsohn P, Munoz R, Youngren M, Zeiss A. Control Your Depression. New York: Prentice Hall; 1986.
73. Beck A, Rush A, Shaw B, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1987.
74. Hays S, Strosahl K, Wilson K. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York: Guilford Press; 1999.
75. Ludman E, Von Korff M, Katon W, et al. The design, implementation, and acceptance of a primary care-based intervention to prevent depression relapse. Int J Psychiatry Med. 2000;30:229-245.
76. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychol Med. 2002;32:959-976.
77. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60:184-189.
78. Rush AJ, Carmody T, Reimitz P-E. The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9:45-59.
79. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18:65-87.
80. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477-486.
81. Azocar F, Cuffel B, McCulloch J, McCabe JF, Tani S, Brodey BB. Monitoring patient improvement and treatment outcomes in managed behavioral health. J Healthc Qual. 2007;29:4-12.
82. Brodey BB, Cuffel B, McCulloch J, et al. The acceptability and effectiveness of patient-reported assessments and feedback in a managed behavioral healthcare setting. Am J Manag Care. 2005;11:774-780.
83. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of latelife depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-2845.
84. Bush T, Rutter C, Simon G, et al. Who benefits from more structured depression treatment? Int J Psychiatry Med. 2004;34:247-258.
85. Rollman BL, Belnap BH, Mazumdar S, et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry. 2005;62:1332-1341.
86. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:629-640.
87. Bower P, Gilbody S, Richards D, Fletcher J, Sutton A. Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry. 2006;189:484-493.
88. Wang PS, Patrick A, Avorn J, et al. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry. 2006;63:1345-1353.
89. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1998;60:143-149.
90. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
91. Simon GE, Katon WJ, VonKorff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158:1638-1644.
92. Sturm R. Economic grand rounds: the myth of medical cost offset. Psychiatr Serv. 2001;52:738-740.